catalyst · primary record
EDARAVONE
FDA filing · 2026-07-17
| Company | AZURITY PHARMACEUTICALS INC |
|---|---|
| Ticker | Not stated |
| Impact | medium |
| Detail | Original Application · Tentative Approval |
| Source | openFDA |
Provenance
- Source: openFDA
- Fetched at: 2026-11-04T03:56:18.109Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: AZURITY PHARMACEUTICALS INC:EDARAVONE:2026-07-17:Original Application · Tentative Approval
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.